AVITA Medical, Inc.
RCEL- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001762303
In the last 90 days, AVITA Medical, Inc. insiders filed 1 open-market purchase and 0 sales; 73 institutions reported holding it in 13F filings for Q2 2026, worth $20.4M in total; no superinvestor holds it.
Other share classesAVHHL
Key figures
- Insider buysLast 90 days, $7.94K in total
- 1
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −4 vs. previous quarter
- 73
- 13F valueReported value at the end of Q2 2026
- $20.4M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding RCEL, Q2 2026
No superinvestor reported holding RCEL at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by AVITA Medical, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 24, 2026 (view filing)5:00 PM ET | Jun 12 | 73 days | O'Toole David DCFO | PPurchase | +2.00K | $3.97 | +$7.94K | +1.3%152.9K after | Amended |
| Jun 10, 2026 (view filing) | Jun 9 | 1 day | Woody Joseph FralinDirector | PPurchase | +5.20K | $4.00 | +$20.8K | +5.1%108.0K after | |
| Jun 9, 2026 (view filing) | Jun 9 | Same day | Woody Joseph FralinDirector | PPurchase | +10.0K | $4.19 | +$41.9K | +10.8%102.8K after | 2 lots |
| Jun 5, 2026 (view filing) | Jun 3 | 2 days | Woody Joseph FralinDirector | PPurchase | +10.0K | $4.10 | +$41.0K | +12.1%92.8K after | 2 lots |
| Jun 3, 2026 (view filing) | Jun 1-2 | 2 days | Woody Joseph FralinDirector | PPurchase | +20.0K | $4.25 | +$85.0K | New position20.0K after | 4 lots |
| May 20, 2026 (view filing) | May 20 | Same day | O'Toole David DCFO | PPurchase | +2.00K | $4.26 | +$8.52K | +1.4%145.9K after | |
| May 19, 2026 (view filing) | May 19 | Same day | O'Toole David DCFO | PPurchase | +2.00K | $4.24 | +$8.48K | +1.4%143.9K after | |
| Mar 11, 2026 (view filing) | Mar 11 | Same day | O'Toole David DCFO | PPurchase | +1.80K | $4.78 | +$8.60K | +1.3%141.9K after | |
| Feb 23, 2026 (view filing) | Feb 19 | 4 days | O'Toole David DCFO | PPurchase | +3.00K | $4.15 | +$12.4K | +2.2%140.1K after | |
| Aug 29, 2025 (view filing) | Aug 28 | 1 day | McNamara RobertDirector | PPurchase | +10.0K | $4.50 | +$45.0K | +13.0%86.8K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in AVITA Medical, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 1,333,914 | $5.51M | 0.00% | −1,238−0.1% | Reduced |
| BlackRock, Inc. | 564,952 | $2.33M | 0.00% | −568,174−50.1% | Reduced |
| Geode Capital Management, LLC | 339,822 | $1.40M | 0.00% | −203,152−37.4% | Reduced |
| Marshall Wace, LLP | 338,387 | $1.40M | 0.00% | +285,825+543.8% | Added |
| AQR Capital Management LLC | 321,013 | $1.33M | 0.00% | +226,652+240.2% | Added |
| Morgan Stanley | 200,462 | $827.9K | 0.00% | +42,841+27.2% | Added |
| Vanguard Fiduciary Trust Co | 182,402 | $753.3K | 0.00% | −11,034−5.7% | Reduced |
| GWM Advisors LLC | 148,931 | $615.1K | 0.00% | +62,046+71.4% | Added |
| Macquarie Group Ltd | 144,164 | $595.4K | 0.00% | +132,262+1,111.3% | Added |
| State Street Corp | 128,977 | $532.7K | 0.00% | −300,045−69.9% | Reduced |